Christopher Heberlig
Director of Finance/CFO chez KSQ Therapeutics, Inc.
Provenance du réseau au premier degré de Christopher Heberlig
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Extinct | Biotechnology | 30 | |
| Public Company | Pharmaceuticals: Major | 28 | |
| Public Company | Biotechnology | 9 | |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Christopher Heberlig via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Rochester Christian University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer General Counsel Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Portfolio Manager-Equities | |
| GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member Chief Executive Officer | |
| VACCINEXPAR | Biotechnology | Director/Board Member Director/Board Member | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Brown University | College/University | Corporate Officer/Principal Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| Boston University | College/University | Graduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Founder Chief Operating Officer Director/Board Member | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| D'Amore-Mckim School of Business | College/University | Masters Business Admin Masters Business Admin | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member Compliance Officer | |
| TFMG Associates LLC | Corporate Officer/Principal | ||
| St Bartholomew's Hospital Medical College | College/University | Corporate Officer/Principal | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Boston College Law School | College/University | Graduate Degree Graduate Degree | |
| Wallace E Carroll School of Management | College/University | Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Graduate Degree Undergraduate Degree | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact Director of Finance/CFO | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The private company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| TALIS BIOMEDICAL CORPORATION | Medical Specialties | Chairman Director/Board Member | |
| KODIAK SCIENCES INC. | Biotechnology | Director/Board Member Director/Board Member | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO General Counsel | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 46 |
| Royaume-Uni | 3 |
| Danemark | 2 |
| Israël | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 34 |
| Consumer Services | 15 |
| Finance | 2 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 257 |
| Corporate Officer/Principal | 118 |
| Independent Dir/Board Member | 95 |
| Undergraduate Degree | 51 |
| Chairman | 41 |
Relations les plus connectées
| Insiders | |
|---|---|
| Alan Crane | 29 |
| Felix Baker | 28 |
| Thomas Tisch | 27 |
| Theo Melas-Kyriazi | 26 |
| Kirk Malloy | 20 |
| Kim Popovits | 19 |
| Mark Kessel | 18 |
| J. Goater | 17 |
| Thomas Malley | 17 |
| Mark Goldberg | 17 |
| Richard Levy | 16 |
| Peter Wirth | 15 |
| Carsten Boess | 15 |
| Thomas Jurgensen | 14 |
| Taylor J. Crouch | 14 |
- Bourse
- Insiders
- Christopher Heberlig
- Connexions Sociétés
